Li‐Fraumeni and Li‐Fraumeni—like syndrome among children diagnosed with pediatric cancer in Southern Brazil
BACKGROUND Pediatric cancers are a feature in patients with Li‐Fraumeni syndrome and its variant Li‐Fraumeni–like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a spec...
Saved in:
Published in | Cancer Vol. 119; no. 24; pp. 4341 - 4349 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, NJ
Wiley-Blackwell
15.12.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND
Pediatric cancers are a feature in patients with Li‐Fraumeni syndrome and its variant Li‐Fraumeni–like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a specific germline mutation in this gene, p.R337H, has been reported at a high prevalence in Brazil.
METHODS
The prevalence of LFS/LFL was investigated in children with cancer who were diagnosed with tumors on the LFS/LFL spectrum and in a small consecutive series of controls without cancer. The prevalence of the germline p.R337H mutation and of other germline TP53 mutations was investigated in a general group of children with cancer and exclusively in children fulfilling the clinical criteria for LFS/LFL, respectively.
RESULTS
Among the 65 children without cancer, 1.5% had a family history of LFL whereas of the 292 children with cancer, 25.3% had a family history of LFL (P < .001). Screening for the p.R337H mutation identified 11 carriers (3.7%), 9 of whom were diagnosed with adrenocortical carcinomas (ACC) and 2 of whom were diagnosed with choroid plexus carcinomas. One of the ACC probands was homozygous mutant. The Brazilian founder haplotype and loss of heterozygosity at the p.R337H locus were present in all carriers. In addition, direct sequencing of the entire TP53 coding region and gene rearrangement analysis of probands fulfilling the criteria for LFL (Eeles 2 criteria, Birch and/or Chompret criteria) and who were negative for the p.R337H mutation revealed a DNA‐binding domain pathogenic mutation, p.G245S, in 1 child.
CONCLUSIONS
TP53 p.R337H testing should be offered to Brazilian children diagnosed with ACC and choroid plexus carcinoma. A significant percentage of children with cancer in southern Brazil fulfill the criteria for LFL and should be referred for genetic risk assessment. Cancer 2013;119:4341–4349. © 2013 American Cancer Society.
In southern Brazil, the TP53 p.R337H mutation is prevalent among children with adrenocortical and choroid plexus carcinomas. A significant percentage (25%) of children with cancer in the current series had a cancer family history fulfilling criteria for Li‐Fraumeni–like syndrome and required referral for genetic risk assessment. |
---|---|
AbstractList | Pediatric cancers are a feature in patients with Li-Fraumeni syndrome and its variant Li-Fraumeni-like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a specific germline mutation in this gene, p.R337H, has been reported at a high prevalence in Brazil.
The prevalence of LFS/LFL was investigated in children with cancer who were diagnosed with tumors on the LFS/LFL spectrum and in a small consecutive series of controls without cancer. The prevalence of the germline p.R337H mutation and of other germline TP53 mutations was investigated in a general group of children with cancer and exclusively in children fulfilling the clinical criteria for LFS/LFL, respectively.
Among the 65 children without cancer, 1.5% had a family history of LFL whereas of the 292 children with cancer, 25.3% had a family history of LFL (P < .001). Screening for the p.R337H mutation identified 11 carriers (3.7%), 9 of whom were diagnosed with adrenocortical carcinomas (ACC) and 2 of whom were diagnosed with choroid plexus carcinomas. One of the ACC probands was homozygous mutant. The Brazilian founder haplotype and loss of heterozygosity at the p.R337H locus were present in all carriers. In addition, direct sequencing of the entire TP53 coding region and gene rearrangement analysis of probands fulfilling the criteria for LFL (Eeles 2 criteria, Birch and/or Chompret criteria) and who were negative for the p.R337H mutation revealed a DNA-binding domain pathogenic mutation, p.G245S, in 1 child.
TP53 p.R337H testing should be offered to Brazilian children diagnosed with ACC and choroid plexus carcinoma. A significant percentage of children with cancer in southern Brazil fulfill the criteria for LFL and should be referred for genetic risk assessment. BACKGROUND Pediatric cancers are a feature in patients with Li‐Fraumeni syndrome and its variant Li‐Fraumeni–like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a specific germline mutation in this gene, p.R337H, has been reported at a high prevalence in Brazil. METHODS The prevalence of LFS/LFL was investigated in children with cancer who were diagnosed with tumors on the LFS/LFL spectrum and in a small consecutive series of controls without cancer. The prevalence of the germline p.R337H mutation and of other germline TP53 mutations was investigated in a general group of children with cancer and exclusively in children fulfilling the clinical criteria for LFS/LFL, respectively. RESULTS Among the 65 children without cancer, 1.5% had a family history of LFL whereas of the 292 children with cancer, 25.3% had a family history of LFL ( P < .001). Screening for the p.R337H mutation identified 11 carriers (3.7%), 9 of whom were diagnosed with adrenocortical carcinomas (ACC) and 2 of whom were diagnosed with choroid plexus carcinomas. One of the ACC probands was homozygous mutant. The Brazilian founder haplotype and loss of heterozygosity at the p.R337H locus were present in all carriers. In addition, direct sequencing of the entire TP53 coding region and gene rearrangement analysis of probands fulfilling the criteria for LFL (Eeles 2 criteria, Birch and/or Chompret criteria) and who were negative for the p.R337H mutation revealed a DNA‐binding domain pathogenic mutation, p.G245S, in 1 child. CONCLUSIONS TP53 p.R337H testing should be offered to Brazilian children diagnosed with ACC and choroid plexus carcinoma. A significant percentage of children with cancer in southern Brazil fulfill the criteria for LFL and should be referred for genetic risk assessment. Cancer 2013;119:4341–4349 . © 2013 American Cancer Society . In southern Brazil, the TP53 p.R337H mutation is prevalent among children with adrenocortical and choroid plexus carcinomas. A significant percentage (25%) of children with cancer in the current series had a cancer family history fulfilling criteria for Li‐Fraumeni–like syndrome and required referral for genetic risk assessment. BACKGROUND Pediatric cancers are a feature in patients with Li‐Fraumeni syndrome and its variant Li‐Fraumeni–like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a specific germline mutation in this gene, p.R337H, has been reported at a high prevalence in Brazil. METHODS The prevalence of LFS/LFL was investigated in children with cancer who were diagnosed with tumors on the LFS/LFL spectrum and in a small consecutive series of controls without cancer. The prevalence of the germline p.R337H mutation and of other germline TP53 mutations was investigated in a general group of children with cancer and exclusively in children fulfilling the clinical criteria for LFS/LFL, respectively. RESULTS Among the 65 children without cancer, 1.5% had a family history of LFL whereas of the 292 children with cancer, 25.3% had a family history of LFL (P < .001). Screening for the p.R337H mutation identified 11 carriers (3.7%), 9 of whom were diagnosed with adrenocortical carcinomas (ACC) and 2 of whom were diagnosed with choroid plexus carcinomas. One of the ACC probands was homozygous mutant. The Brazilian founder haplotype and loss of heterozygosity at the p.R337H locus were present in all carriers. In addition, direct sequencing of the entire TP53 coding region and gene rearrangement analysis of probands fulfilling the criteria for LFL (Eeles 2 criteria, Birch and/or Chompret criteria) and who were negative for the p.R337H mutation revealed a DNA‐binding domain pathogenic mutation, p.G245S, in 1 child. CONCLUSIONS TP53 p.R337H testing should be offered to Brazilian children diagnosed with ACC and choroid plexus carcinoma. A significant percentage of children with cancer in southern Brazil fulfill the criteria for LFL and should be referred for genetic risk assessment. Cancer 2013;119:4341–4349. © 2013 American Cancer Society. In southern Brazil, the TP53 p.R337H mutation is prevalent among children with adrenocortical and choroid plexus carcinomas. A significant percentage (25%) of children with cancer in the current series had a cancer family history fulfilling criteria for Li‐Fraumeni–like syndrome and required referral for genetic risk assessment. BACKGROUNDPediatric cancers are a feature in patients with Li-Fraumeni syndrome and its variant Li-Fraumeni-like syndrome (LFS/LFL). To the best of the authors' knowledge, TP53 germline mutations are currently the only molecular defect known to be associated with this disease. Recently, a specific germline mutation in this gene, p.R337H, has been reported at a high prevalence in Brazil.METHODSThe prevalence of LFS/LFL was investigated in children with cancer who were diagnosed with tumors on the LFS/LFL spectrum and in a small consecutive series of controls without cancer. The prevalence of the germline p.R337H mutation and of other germline TP53 mutations was investigated in a general group of children with cancer and exclusively in children fulfilling the clinical criteria for LFS/LFL, respectively.RESULTSAmong the 65 children without cancer, 1.5% had a family history of LFL whereas of the 292 children with cancer, 25.3% had a family history of LFL (P < .001). Screening for the p.R337H mutation identified 11 carriers (3.7%), 9 of whom were diagnosed with adrenocortical carcinomas (ACC) and 2 of whom were diagnosed with choroid plexus carcinomas. One of the ACC probands was homozygous mutant. The Brazilian founder haplotype and loss of heterozygosity at the p.R337H locus were present in all carriers. In addition, direct sequencing of the entire TP53 coding region and gene rearrangement analysis of probands fulfilling the criteria for LFL (Eeles 2 criteria, Birch and/or Chompret criteria) and who were negative for the p.R337H mutation revealed a DNA-binding domain pathogenic mutation, p.G245S, in 1 child.CONCLUSIONSTP53 p.R337H testing should be offered to Brazilian children diagnosed with ACC and choroid plexus carcinoma. A significant percentage of children with cancer in southern Brazil fulfill the criteria for LFL and should be referred for genetic risk assessment. |
Author | Cossio, Silvia L. Roth, Daniela E. Rossi, Cristina Brunetto, Algemir L. Camey, Suzi A. Ashton‐Prolla, Patricia Goldim, Jose R. Santos‐Silva, Patricia Zagonel‐Oliveira, Marcelo Hainaut, Pierre Pereira, Fernando S. Martel‐Planche, Ghyslaine Giacomazzi, Juliana Netto, Cristina B. Selistre, Simone G. Alemar, Barbara |
Author_xml | – sequence: 1 givenname: Juliana surname: Giacomazzi fullname: Giacomazzi, Juliana organization: UFRGS – sequence: 2 givenname: Simone G. surname: Selistre fullname: Selistre, Simone G. organization: Hospital de Clinicas de Porto Alegre – sequence: 3 givenname: Cristina surname: Rossi fullname: Rossi, Cristina organization: UFRGS – sequence: 4 givenname: Barbara surname: Alemar fullname: Alemar, Barbara organization: UFRGS – sequence: 5 givenname: Patricia surname: Santos‐Silva fullname: Santos‐Silva, Patricia organization: Universidade Federal do Rio Grande do Sul (UFRGS) – sequence: 6 givenname: Fernando S. surname: Pereira fullname: Pereira, Fernando S. organization: UFRGS – sequence: 7 givenname: Cristina B. surname: Netto fullname: Netto, Cristina B. organization: Hospital de Clinicas de Porto Alegre – sequence: 8 givenname: Silvia L. surname: Cossio fullname: Cossio, Silvia L. organization: Universidade Federal do Rio Grande do Sul (UFRGS) – sequence: 9 givenname: Daniela E. surname: Roth fullname: Roth, Daniela E. organization: Hospital de Clinicas de Porto Alegre – sequence: 10 givenname: Algemir L. surname: Brunetto fullname: Brunetto, Algemir L. organization: Hospital de Clinicas de Porto Alegre – sequence: 11 givenname: Marcelo surname: Zagonel‐Oliveira fullname: Zagonel‐Oliveira, Marcelo organization: UFRGS – sequence: 12 givenname: Ghyslaine surname: Martel‐Planche fullname: Martel‐Planche, Ghyslaine organization: International Agency for Research on Cancer – sequence: 13 givenname: Jose R. surname: Goldim fullname: Goldim, Jose R. organization: Hospital de Clinicas de Porto Alegre – sequence: 14 givenname: Pierre surname: Hainaut fullname: Hainaut, Pierre organization: International Prevention Research Institute – sequence: 15 givenname: Suzi A. surname: Camey fullname: Camey, Suzi A. organization: UFRGS – sequence: 16 givenname: Patricia surname: Ashton‐Prolla fullname: Ashton‐Prolla, Patricia organization: Hospital de Clinicas de Porto Alegre |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28032845$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24122735$$D View this record in MEDLINE/PubMed |
BookMark | eNp90M9r2zAUwHFRWto07aV_wNBlMAZOJVmypeMW-mMQWlg36M3I0nOizZZTKaakp_4JO_QvzF9SZ043dtlJ6PHhPfgeo33fekDojJIJJYSdG2_ChMmUZ3toRInKE0I520cjQohMBE_vj9BxjD_6b85EeoiOGKeM5akYoYeZ2zz_ugy6a8A7rL3F_0w2zy-1-wk4rr0NbQNYN62fY7NwtQ3gsXV67tsIFj-61QIvoR-sgjPYaG8gYOfxXdutFhA8_hz0k6tP0EGl6winu3eMvl9efJteJ7Pbqy_TT7PEcKayhIMphSSVVpXUYKgVQpoqtxWxkPJSMCMUL7NUK2sVVIwqaqnMFORKZ8TIdIw-DHuXoX3oIK6KxkUDda09tF0sKM8EzTOS8Z5-HKgJbYwBqmIZXKPDuqCk2CYutomL34l7_G63tysbsH_oW9MevN8BHY2uq9CXcPGvkyRlkm8dHdyjq2H9n5PF9Gb6dTj-CoAGmd0 |
CODEN | CANCAR |
CitedBy_id | crossref_primary_10_1200_JCO_2015_61_5757 crossref_primary_10_1371_journal_pone_0140356 crossref_primary_10_3390_jcm11226641 crossref_primary_10_1002_ggn2_10033 crossref_primary_10_1016_j_cct_2016_07_011 crossref_primary_10_1158_0008_5472_CAN_16_2179 crossref_primary_10_1590_1678_4685_gmb_2014_0362 crossref_primary_10_1111_tbj_12308 crossref_primary_10_1093_neuonc_noz108 crossref_primary_10_1093_carcin_bgx089 crossref_primary_10_18632_oncotarget_17225 crossref_primary_10_1016_j_cancergen_2019_11_005 crossref_primary_10_1002_cncr_33143 crossref_primary_10_1007_s10549_016_4003_9 crossref_primary_10_1590_1806_9282_61_03_282 crossref_primary_10_1002_mgg3_1168 crossref_primary_10_1007_s10689_017_0028_4 crossref_primary_10_1097_PAP_0000000000000363 crossref_primary_10_2217_fon_2016_0236 crossref_primary_10_1111_bjh_14461 crossref_primary_10_3389_fgene_2021_606537 crossref_primary_10_1007_s00277_017_3143_2 crossref_primary_10_1016_j_mce_2017_05_014 crossref_primary_10_1371_journal_pone_0143262 crossref_primary_10_1097_CCO_0000000000000200 crossref_primary_10_1038_s41379_018_0042_6 crossref_primary_10_2139_ssrn_4012663 crossref_primary_10_1016_j_gene_2023_148069 crossref_primary_10_1002_humu_22559 crossref_primary_10_1200_GO_23_00006 crossref_primary_10_3389_fonc_2021_751784 crossref_primary_10_1111_cge_14042 |
Cites_doi | 10.1093/jnci/90.8.606 10.1016/S0378-4274(98)00311-7 10.1126/science.1659741 10.1136/jmg.2004.030551 10.1038/sj.onc.1204621 10.1073/pnas.161479898 10.1148/rg.311105099 10.1200/JCO.2009.22.7967 10.1007/s00423-011-0868-6 10.1186/1471-2407-8-357 10.1016/j.canlet.2005.12.039 10.1016/j.ejca.2005.11.032 10.1002/cncr.25826 10.1136/jmg.2008.057570 10.1136/jmg.39.12.941 10.1002/humu.21151 10.1001/jama.1982.03320440040031 10.1210/jcem.86.10.7957 10.1210/jc.2011-1982 10.1054/bjoc.2000.1167 10.1136/jmg.38.1.43 10.1126/science.1978757 10.1006/gyno.2002.6673 10.1038/sj.onc.1207714 10.1016/j.canlet.2007.10.044 10.1371/journal.pone.0018015 10.1002/ijc.2910420408 10.1200/JCO.2008.16.6959 10.1038/35077207 |
ContentType | Journal Article |
Copyright | 2013 American Cancer Society 2015 INIST-CNRS 2013 American Cancer Society. |
Copyright_xml | – notice: 2013 American Cancer Society – notice: 2015 INIST-CNRS – notice: 2013 American Cancer Society. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1002/cncr.28346 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-0142 |
EndPage | 4349 |
ExternalDocumentID | 10_1002_cncr_28346 24122735 28032845 CNCR28346 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | South America Brazil America |
GeographicLocations_xml | – name: Brazil |
GrantInformation_xml | – fundername: FAPERGS (PPSUS 2009), Brazil – fundername: Fundo de Incentivo a Pesquisa do Hospital de Clínicas de Porto Alegre, Brazil (FIPE‐HCPA) – fundername: Ethnic Research Initiative Grant from GlaxoSmithKline, UK |
GroupedDBID | --- -~X .3N .GA .Y3 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AARRQ AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AGNAY AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT .GJ 08R 31~ 3O- AAJUZ AAVGM ABCVL ABFLS ABHUG ABPTK ABWRO ACCFJ ACXME ADAWD ADDAD ADGIM AEEZP AEQDE AFFNX AFVGU AGJLS AI. AIWBW AJBDE C1A HF~ H~9 IPNFZ IQODW J5H N4W NEJ OHT RSU VH1 WHG XFK Y6R YQJ ZA5 ZXP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c4296-4ecb580fa9f8aec1d558cf7df0de34b52c594b63a9dd9ef2191d1869e79a60c83 |
IEDL.DBID | DR2 |
ISSN | 0008-543X |
IngestDate | Sat Aug 17 03:41:32 EDT 2024 Fri Aug 23 00:56:01 EDT 2024 Sat Sep 28 07:52:35 EDT 2024 Thu Nov 24 18:28:45 EST 2022 Sat Aug 24 00:58:07 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 24 |
Keywords | Human Pediatrics Multiple TP53 p.R337H mutation Malignant tumor Genetic disease Li-Fraumeni-like syndrome TP53 mutations Cancerology TP53 Gene Genetics childhood cancer Diagnosis Mutation Child Cancer Tumor suppressor gene Li-Fraumeni syndrome |
Language | English |
License | CC BY 4.0 2013 American Cancer Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4296-4ecb580fa9f8aec1d558cf7df0de34b52c594b63a9dd9ef2191d1869e79a60c83 |
Notes | We thank Cláudio Galvão, Lauro Greggianin, Camila Matzenbacher Bittar, and Filippo Vairo for their collaboration with patient recruitment; Diego D'Avila Paskulin, Marcia da Silveira Graudenz, and Luise Meurer for laboratory support; and Lavinia Schuler‐Faccini and INaGeMP for their help with geomapping. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.28346 |
PMID | 24122735 |
PQID | 1465176064 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1465176064 crossref_primary_10_1002_cncr_28346 pubmed_primary_24122735 pascalfrancis_primary_28032845 wiley_primary_10_1002_cncr_28346_CNCR28346 |
PublicationCentury | 2000 |
PublicationDate | 15 December 2013 |
PublicationDateYYYYMMDD | 2013-12-15 |
PublicationDate_xml | – month: 12 year: 2013 text: 15 December 2013 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken, NJ |
PublicationPlace_xml | – name: Hoboken, NJ – name: United States |
PublicationTitle | Cancer |
PublicationTitleAlternate | Cancer |
PublicationYear | 2013 |
Publisher | Wiley-Blackwell |
Publisher_xml | – name: Wiley-Blackwell |
References | 2002; 39 2007; 245 2010; 31 2011; 117 1991; 254 2012 2004; 23 2011; 31 2008; 8 2006 1982; 247 2001; 88 2011; 6 2009; 27 2008; 261 2012; 97 2001; 20 2001; 86 2006; 42 2012; 397 2006; 43 1995; 25 1988; 48 1969; 43 1997; 57 1998; 102–103 1998; 90 2008; 45 2000; 82 2001; 38 1988; 42 2003; 222 2001; 411 1994; 54 2003; 88 1990; 250 2001; 98 e_1_2_7_6_1 Eeles RA (e_1_2_7_15_1) 1995; 25 e_1_2_7_5_1 Frebourg T (e_1_2_7_39_1) 2001; 88 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_7_1 e_1_2_7_19_1 Li FP (e_1_2_7_8_1) 1969; 43 Birch JM (e_1_2_7_16_1) 1994; 54 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_41_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 Varley JM (e_1_2_7_25_1) 1997; 57 Varley J (e_1_2_7_21_1) 2003; 222 e_1_2_7_30_1 Li FP (e_1_2_7_14_1) 1988; 48 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 |
References_xml | – volume: 43 start-page: 1365 year: 1969 end-page: 1373 article-title: Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome publication-title: J Natl Cancer Inst. – volume: 20 start-page: 4621 year: 2001 end-page: 4628 article-title: Relative frequency and morphology of cancers in carriers of germline TP53 mutations publication-title: Oncogene. – volume: 54 start-page: 1298 year: 1994 end-page: 1304 article-title: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li‐Fraumeni families publication-title: Cancer Res. – volume: 31 start-page: 263 year: 2011 end-page: 280 article-title: Imaging of cancer predisposition syndromes in children publication-title: Radiographics. – volume: 27 start-page: e108 year: 2009 end-page: e109 article-title: 2009 version of the Chompret criteria for Li Fraumeni syndrome publication-title: J Clin Oncol. – volume: 397 start-page: 209 year: 2012 end-page: 216 article-title: Clinical impact of TP53 alterations in adrenocortical carcinomas publication-title: Langenbecks Arch Surg. – volume: 57 start-page: 3245 year: 1997 end-page: 3252 article-title: Germ‐line mutations of TP53 in Li‐Fraumeni families: an extended study of 39 families publication-title: Cancer Res. – volume: 261 start-page: 21 year: 2008 end-page: 25 article-title: Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil publication-title: Cancer Lett. – volume: 6 start-page: e18015 year: 2011 article-title: Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil publication-title: PLoS One. – volume: 31 start-page: 143 year: 2010 end-page: 150 article-title: Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect publication-title: Hum Mutat. – volume: 38 start-page: 43 year: 2001 end-page: 47 article-title: Sensitivity and predictive value of criteria for p53 germline mutation screening publication-title: J Med Genet. – volume: 45 start-page: 535 year: 2008 end-page: 538 article-title: Molecular basis of the Li‐Fraumeni syndrome: an update from the French LFS families publication-title: J Med Genet. – volume: 88 start-page: 581 year: 2001 end-page: 587 article-title: Li‐Fraumeni syndrome: update, new data and guidelines for clinical management publication-title: Bull Cancer. – volume: 98 start-page: 9330 year: 2001 end-page: 9335 article-title: An inherited p53 mutation that contributes in a tissue‐specific manner to pediatric adrenal cortical carcinoma publication-title: Proc Natl Acad Sci U S A. – volume: 88 start-page: S4 issue: 1 pt 2 year: 2003 end-page: S7 article-title: General keynote: hereditary cancer: lessons from Li‐Fraumeni syndrome publication-title: Gynecol Oncol. – year: 2012 – volume: 254 start-page: 1138 year: 1991 end-page: 1146 article-title: Tumor suppressor genes publication-title: Science. – volume: 90 start-page: 606 year: 1998 end-page: 611 article-title: Multiple primary cancers in families with Li‐Fraumeni syndrome publication-title: J Natl Cancer Inst. – volume: 97 start-page: E476 year: 2012 end-page: E485 article-title: TP53 germline mutations in adult patients with adrenocortical carcinoma publication-title: J Clin Endocrinol Metab. – volume: 82 start-page: 1932 year: 2000 end-page: 1937 article-title: P53 germline mutations in childhood cancers and cancer risk for carrier individuals publication-title: Br J Cancer. – volume: 102–103 start-page: 227 year: 1998 end-page: 234 article-title: Epidemiology of cancer: global patterns and trends publication-title: Toxicol Lett. – volume: 42 start-page: 511 year: 1988 end-page: 520 article-title: The international incidence of childhood cancer publication-title: Int J Cancer. – volume: 245 start-page: 96 year: 2007 end-page: 102 article-title: The TP53 mutation, R337H, is associated with Li‐Fraumeni and Li‐Fraumeni‐like syndromes in Brazilian families publication-title: Cancer Lett. – volume: 247 start-page: 2692 year: 1982 end-page: 2694 article-title: Prospective study of a family cancer syndrome publication-title: JAMA. – volume: 8 start-page: 357 year: 2008 article-title: Association of the germline TP53 R337H mutation with breast cancer in southern Brazil publication-title: BMC Cancer. – year: 2006 – volume: 27 start-page: 1250 year: 2009 end-page: 1256 article-title: Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations publication-title: J Clin Oncol. – volume: 42 start-page: 1143 year: 2006 end-page: 1150 article-title: BRCA1, BRCA2 and TP53 mutations in very early‐onset breast cancer with associated risks to relatives publication-title: Eur J Cancer. – volume: 23 start-page: 6445 year: 2004 end-page: 6470 article-title: Highly penetrant hereditary cancer syndromes publication-title: Oncogene. – volume: 411 start-page: 336 year: 2001 end-page: 341 article-title: Cancer genetics publication-title: Nature. – volume: 39 start-page: 941 year: 2002 end-page: 944 article-title: Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li‐Fraumeni syndrome publication-title: J Med Genet. – volume: 117 start-page: 2228 year: 2011 end-page: 2235 article-title: Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil publication-title: Cancer. – volume: 48 start-page: 5358 year: 1988 end-page: 5362 article-title: A cancer family syndrome in twenty‐four kindreds publication-title: Cancer Res. – volume: 25 start-page: 101 year: 1995 end-page: 124 article-title: Germline mutations in the TP53 gene publication-title: Cancer Surv. – volume: 43 start-page: 91 year: 2006 end-page: 96 article-title: Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation publication-title: J Med Genet. – volume: 222 start-page: 117 year: 2003 end-page: 129 article-title: TP53, hChk2, and the Li‐Fraumeni syndrome publication-title: Methods Mol Biol. – volume: 250 start-page: 1233 year: 1990 end-page: 1238 article-title: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms publication-title: Science. – volume: 86 start-page: 4970 year: 2001 end-page: 4973 article-title: An inherited mutation outside the highly conserved DNA‐binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors publication-title: J Clin Endocrinol Metab. – ident: e_1_2_7_10_1 doi: 10.1093/jnci/90.8.606 – volume: 222 start-page: 117 year: 2003 ident: e_1_2_7_21_1 article-title: TP53, hChk2, and the Li‐Fraumeni syndrome publication-title: Methods Mol Biol. contributor: fullname: Varley J – ident: e_1_2_7_37_1 – volume: 48 start-page: 5358 year: 1988 ident: e_1_2_7_14_1 article-title: A cancer family syndrome in twenty‐four kindreds publication-title: Cancer Res. contributor: fullname: Li FP – ident: e_1_2_7_5_1 doi: 10.1016/S0378-4274(98)00311-7 – ident: e_1_2_7_41_1 doi: 10.1126/science.1659741 – ident: e_1_2_7_3_1 – volume: 43 start-page: 1365 year: 1969 ident: e_1_2_7_8_1 article-title: Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome publication-title: J Natl Cancer Inst. contributor: fullname: Li FP – ident: e_1_2_7_28_1 doi: 10.1136/jmg.2004.030551 – ident: e_1_2_7_11_1 doi: 10.1038/sj.onc.1204621 – ident: e_1_2_7_26_1 doi: 10.1073/pnas.161479898 – ident: e_1_2_7_7_1 doi: 10.1148/rg.311105099 – ident: e_1_2_7_19_1 doi: 10.1200/JCO.2009.22.7967 – ident: e_1_2_7_34_1 doi: 10.1007/s00423-011-0868-6 – volume: 25 start-page: 101 year: 1995 ident: e_1_2_7_15_1 article-title: Germline mutations in the TP53 gene publication-title: Cancer Surv. contributor: fullname: Eeles RA – volume: 57 start-page: 3245 year: 1997 ident: e_1_2_7_25_1 article-title: Germ‐line mutations of TP53 in Li‐Fraumeni families: an extended study of 39 families publication-title: Cancer Res. contributor: fullname: Varley JM – ident: e_1_2_7_32_1 doi: 10.1186/1471-2407-8-357 – ident: e_1_2_7_29_1 doi: 10.1016/j.canlet.2005.12.039 – ident: e_1_2_7_12_1 doi: 10.1016/j.ejca.2005.11.032 – ident: e_1_2_7_33_1 doi: 10.1002/cncr.25826 – ident: e_1_2_7_2_1 – volume: 54 start-page: 1298 year: 1994 ident: e_1_2_7_16_1 article-title: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li‐Fraumeni families publication-title: Cancer Res. contributor: fullname: Birch JM – ident: e_1_2_7_40_1 doi: 10.1136/jmg.2008.057570 – ident: e_1_2_7_24_1 doi: 10.1136/jmg.39.12.941 – ident: e_1_2_7_36_1 doi: 10.1002/humu.21151 – ident: e_1_2_7_38_1 – ident: e_1_2_7_13_1 doi: 10.1001/jama.1982.03320440040031 – ident: e_1_2_7_27_1 doi: 10.1210/jcem.86.10.7957 – ident: e_1_2_7_35_1 doi: 10.1210/jc.2011-1982 – ident: e_1_2_7_18_1 doi: 10.1054/bjoc.2000.1167 – ident: e_1_2_7_17_1 doi: 10.1136/jmg.38.1.43 – ident: e_1_2_7_9_1 doi: 10.1126/science.1978757 – volume: 88 start-page: 581 year: 2001 ident: e_1_2_7_39_1 article-title: Li‐Fraumeni syndrome: update, new data and guidelines for clinical management publication-title: Bull Cancer. contributor: fullname: Frebourg T – ident: e_1_2_7_6_1 – ident: e_1_2_7_22_1 doi: 10.1006/gyno.2002.6673 – ident: e_1_2_7_20_1 doi: 10.1038/sj.onc.1207714 – ident: e_1_2_7_30_1 doi: 10.1016/j.canlet.2007.10.044 – ident: e_1_2_7_31_1 doi: 10.1371/journal.pone.0018015 – ident: e_1_2_7_4_1 doi: 10.1002/ijc.2910420408 – ident: e_1_2_7_23_1 doi: 10.1200/JCO.2008.16.6959 – ident: e_1_2_7_42_1 doi: 10.1038/35077207 |
SSID | ssj0007253 |
Score | 2.3249633 |
Snippet | BACKGROUND
Pediatric cancers are a feature in patients with Li‐Fraumeni syndrome and its variant Li‐Fraumeni–like syndrome (LFS/LFL). To the best of the... Pediatric cancers are a feature in patients with Li-Fraumeni syndrome and its variant Li-Fraumeni-like syndrome (LFS/LFL). To the best of the authors'... BACKGROUNDPediatric cancers are a feature in patients with Li-Fraumeni syndrome and its variant Li-Fraumeni-like syndrome (LFS/LFL). To the best of the... |
SourceID | proquest crossref pubmed pascalfrancis wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 4341 |
SubjectTerms | Adolescent Adrenal Cortex Neoplasms - genetics Adrenocortical Carcinoma - genetics Biological and medical sciences Brazil Carcinoma - genetics Child Child, Preschool childhood cancer Choroid Plexus Neoplasms - genetics Female Gene Rearrangement Genes, p53 Genetic Predisposition to Disease Germ-Line Mutation Humans Infant Li-Fraumeni Syndrome - genetics Li‐Fraumeni syndrome Li‐Fraumeni–like syndrome Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasms - genetics Prevalence TP53 mutations TP53 p.R337H mutation Tumor Suppressor Protein p53 - genetics Tumors |
Title | Li‐Fraumeni and Li‐Fraumeni—like syndrome among children diagnosed with pediatric cancer in Southern Brazil |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.28346 https://www.ncbi.nlm.nih.gov/pubmed/24122735 https://search.proquest.com/docview/1465176064 |
Volume | 119 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CDqVQ2vS9TRpU2lPBG1uW_IBckiUhlCaH0MBeitFjDCZB2Xp3LznlJ-SQX5hf0pG83mVLKLQ3IySQNaOZT6_vA_iSWp4XtYgjS_mBFihWRYpwcaQyxbVJVSnDQ-HTs-zkQnwby_EG7PdvYTp-iOWGm58ZIV77Ca70dG9FGmqcaYeUHIXn2_ZMeh4Rna-4o3K-oKCMi0iKdLzkJuV7q6Zr2ejZRE1pYOpO0eIxyLmOYEMKOn4BP_vOdzdPLofzmR6amz94Hf_377bg-QKbsoPOmV7CBrpX8OR0cfr-Gn59bx5u7wjqUjxzDVPOsrWSh9v7q-YSWc-CwIKSEevfizPbXetDy_zuL5v0KiHMeNdrWeNYUPTD1rHDVt00V2_g4vjox-gkWkg2RIYSWxYJNFoWca3KulBoEitlYerc1rHFVGjJjSyFzsgHrC2xpnCZWC-KhXmpstgU6VvYdNcO3wPLEdEH30JnllAHV1rzBAuL2vJayXIAn3vTVZOOmaPqOJh55UevCqM3gN01qy6relUuSs1yAJ96M1c0s_xxiXJ4PZ_6RZFMclrgiQG86-y_ai0STsCPWn8NVvxLD6rR2eg8fH34l8rb8JR75Y2ER4ncgc1ZO8ePhH9mejf4-W-ZtwZ_ |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFL0qrQSVEOXRQqCUQbBCcmqPZ_xYQtQqQJJF1UrZWfOyZLWaBifZdNVPYMEX9ku4M7YTBVVIsLOsGcmeuY9z53EOwMdY0zQrWRhozA9YoGgRCMTFgUgElSoWOfcXhceTZHjBvk35tD2b4-7CNPwQqwU35xk-XjsHdwvSx2vWUGVV3cfsyJIHsIP-zn1FdbZmj0ppS0IZZgFn8XTFTkqP13038tHjmZjj0JSNpsV9oHMTw_okdLrXKK3OPXehO3ty2V8uZF_d_MHs-N__9xSetPCUfG7s6RlsGfscHo7bDfgX8GNU3d3-RLSLIc1WRFhNNt7c3f66qi4N6YgQiBczIt2VcaKbk31GE7cATGadUAhRzvpqUlniRf1MbcmXWtxUV_twcXpyPhgGrWpDoDC3JQEzSvIsLEVeZsKoSHOeqTLVZahNzCSniudMJmgGWuemxIgZaaeLZdJcJKHK4gPYttfWvAKSGmNc_M1kohF4UCEljUymjdS0FDzvwYdu7opZQ85RNDTMtHCjV_jR68HRxrSumjphLszOvAfvu3ku0Lncjomw5no5d3URj1Ks8VgPXjYGsO7NIorYD3t_8tP4ly8oBpPBmX96_S-N38Gj4fl4VIy-Tr6_gV3qhDgiGkT8ELYX9dK8RTi0kEfe6H8D8ccKoQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxQxFD7UCkUo9W7XS43okzDbmUwyF-hL3bpUbRcpFvZFhlxOYGhJt9Pdlz71J_jgL-wvMcns7LIigr4NIYFMzsk5X27fB_Au1TQvDIsj7fKDW6BoEQmHiyORCSpVKkoeHgofj7LDU_Z5zMdrsNe9hWn5IRYbbn5mhHjtJ_hEm90laaiyqum75MiyO3CXZSn1Pn1wsiSPyumcgzIuIs7S8YKclO4u266ko82JuHIjY1pJiz9hzlUIG3LQ8D5873rfXj0568-msq-ufyN2_N_fewBbc3BK9ltveghraB_BxvH8-P0xXB7Vtzc_HNZ1Ac3WRFhNVkpub36e12dIOhoEEqSMSPdgnOj2Xh9q4rd_yaSTCSHK-15DakuCpB82lnxoxHV9_gROhx-_DQ6juWZDpFxmyyKGSvIiNqI0hUCVaM4LZXJtYo0pk5wqXjKZOSfQukTj4mWivSoW5qXIYlWkT2HdXljcBpIjoo--hcy0gx1USEkTLDRKTY3gZQ_edqarJi01R9WSMNPKj14VRq8HOytWXVT1slwuN_MevOnMXLmp5c9LhMWL2ZVfFfEkdys81oNnrf2XrVlCHfJzrd8HK_6lB9VgNDgJX8__pfJr2Ph6MKyOPo2-vIB71KtwJDRK-EtYnzYzfOWw0FTuBJf_BeEHCVA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Li-Fraumeni+and+Li-Fraumeni-Like+Syndrome+Among+Children+Diagnosed+With+Pediatric+Cancer+in+Southern+Brazil&rft.jtitle=Cancer&rft.au=GIACOMAZZI%2C+Juliana&rft.au=SELISTRE%2C+Simone+G&rft.au=ZAGONEL-OLIVEIRA%2C+Marcelo&rft.au=MARTEL-PLANCHE%2C+Ghyslaine&rft.date=2013-12-15&rft.pub=Wiley-Blackwell&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=119&rft.issue=24&rft.spage=4341&rft.epage=4349&rft_id=info:doi/10.1002%2Fcncr.28346&rft.externalDBID=n%2Fa&rft.externalDocID=28032845 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |